Article Text

Download PDFPDF

2022-RA-1526-ESGO Risk factors for sentinel lymph node involvement in patients with apparent early-stage endometrial cancer: a retrospective single-center study
  1. Giuseppe Deo1,
  2. Maria Luisa Fais1,
  3. Alfonso Altieri1,
  4. Giulia Carboni1,
  5. Giuseppina Fais1,
  6. Andrea Ungredda1,
  7. Daniela Fanni2,
  8. Elena Massa3,
  9. Valerio Mais1,
  10. Stefano Angioni1 and
  11. Michele Peiretti1
  1. 1Department of Surgical Sciences, Division of Gynecology and Obstetrics, University of Cagliari, Cagliari, Italy
  2. 2UOC Anatomia Patologica, AOU Cagliari, University of Cagliari, Cagliari, Italy
  3. 3Medical Oncology Unit, University of Cagliari, Cagliari, Italy


Introduction/Background Sentinel lymph node (SLN) mapping with indocyanine green (ICG) has become the standard of care in apparent early-stage endometrial cancer. The aim of this study is to evaluate the possible risk factors (RFs) for lymph-nodal metastases, differentiating by the type of metastasis.

Methodology This is an observational single-center retrospective study. We reviewed 96 patients with a diagnosis of apparent early-stage endometrial cancer submitted to hysterectomy with salpingo-oophorectomy and SLN mapping from December 2015 to March 2022. Possible RFs for nodal metastasis were considered including clinical (age, BMI), and biochemical (CA125, CA 19.9, HE-4) parameters, anatomopathological characteristics (Myometral invasion – MI, Lymphovascular space invasion (LVSI), grade, histotype) and immunohistochemical findings (L1CAM, Ki67, estrogen receptor – ER, progesterone receptor- PR). Odds ratios (ORs) were calculated, and then RFs were confronted with logistic regression.

Results Overall detection rate was 94.8%, 83.3% bilateral, and 11.5% unilateral. We removed 181 suspected SLNs. The preponderance of SLNs was found at the external iliac and interiliac stations (69%). 7 patients had macrometastases, 5 micrometastases, and 7 ITCs. Higher ER percentage resulted in a protective factor (PF) for lymph nodal metastasis. MI more than 50%, LVSI, and p53 positivity resulted in RFs for lymph nodal metastases. Histotype, age, and L1CAM showed a slight, not significant, correlation as possible RFs. The multivariate multinomial analysis didn’t find any statistically significant differences between the RFs and the type of metastasis.

Abstract 2022-RA-1526-ESGO Table 1

Impact of possible risk factors on model involvement

Conclusion Our study shows a good SLN detection rate in line with the literature. The multivariate multinomial analysis shows that there are no differences in the RFs for the different types of metastases suggesting that these entities are a pathological continuum. Further studies are needed.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.